STAT

OCTOBER 12, 2023

Good morning, everyone, and welcome to another busy day. We are scrambling, in fact, to update our to-do list, schedule online calls, and sort out deadlines. To cope, we are quaffing several cups of stimulation, of course. Our choice today is maple bourbon. Meanwhile, here is the latest selection of interesting items for you to peruse.

100

100

Fierce Pharma

FEBRUARY 13, 2024

It’s the approval Ipsen has been waiting for since buying up Onivyde in 2017. It’s the approval Ipsen has been waiting for since buying up Onivyde in 2017. The FDA has approved Onivyde as part of a combination dubbed Nalirifox to treat patients with newly diagnosed metastatic pancreatic cancer.

FDA 125

FDA 125

Med Ed 101

DECEMBER 3, 2017

For those of you looking for BCPS help in the next year or two, you better not wait any longer – This one time only initial offer will end Monday December 4th, 2017! The post Day 1 – ASHP Midyear Meeting 2017 appeared first on Med Ed 101.

40

40

Med Ed 101

FEBRUARY 8, 2017

Where are we at with 2017 Pharmacist Provider Status? The post 2017 Pharmacist Provider Status Update appeared first on Med Ed 101. Since the heated election, a host of topics and discussions have been held on National debt and Healthcare. There is really positive news regarding pharmacist provider status.

40

40

Med Ed 101

DECEMBER 6, 2017

The post ASHP Midyear 2017 Day 4 appeared first on Med Ed 101. Hope you all enjoyed it, and maybe I will head back next year…we’ll see! Day 4 of ASHP Midyear took on a medication safety theme. I took part in a pain management in opioid use […].

40

40

Med Ed 101

DECEMBER 5, 2017

The post ASHP Midyear Day 2 2017 appeared first on Med Ed 101. With ongoing discussions today with more pharmacists, residents and students, I can’t help but think what pharmacy is going to look like in 10 or 20 years. I think the key to identifying what’s going to happen is to think […].

40

40

Med Ed 101

DECEMBER 13, 2017

The post New Hypertension Guideline Update – 2017 appeared first on Med Ed 101. I outline some of the important differences in the presentation below. I have also added this to the 20+ hour BCPS pharmacotherapy webinar. I’m giving year long access for […].

40

40

Med Ed 101

JANUARY 7, 2018

I’m a few days late to the game here, but I wanted to share my 3 biggest clinical pharmacy changes from 2017. My opinion of course, and I’d love it if you would post one or two things below that you felt were important clinical updates in 2017. How did I select these? Without further […].

40

40

Fierce Healthcare

APRIL 19, 2024

The company, which launched in 2017, has contracts with four cities for its network of AEDs to improve survival rates of sudden cardiac arrest. Portable defibrillator company Avive Solutions raised $56.5 million in growth equity financing to build out its staff and commercial developments. |

105

105

pharmaphorum

APRIL 8, 2024

Less than half of the cancer therapies given accelerated approval by the FDA in 2013 to 2017 showed a clinical benefit in a confirmatory trial within the next five years

FDA 110

FDA 110

Pharmacy Times

APRIL 11, 2024

Benralizumab was previously approved by the FDA in 2017 as an add-on maintenance therapy for patients 12 years and older.

FDA 111

FDA 111

Fierce Pharma

APRIL 8, 2024

Many cancer meds approved under the FDA's accelerated approval pathway from 2013 to 2017 didn't improve overall survival after more than five years of follow-up research, the study found. One hallmark of the FDA's accelerated approval pathway is the requirement that medicines prove their benefits in confirmatory trials.

FDA 120

FDA 120

Drug Topics

MARCH 4, 2024

In 2017, dupilumab became the first treatment approved in Canada for moderate to severe AD, as multiple clinical trials demonstrated its effectiveness and safety.

98

98

Fierce Pharma

MARCH 20, 2024

After Johnson & Johnson last year changed its mind on its 2017 purchase of ap | Idorsia's Tryvio is the first oral anti-hypertensive therapy that uses a new therapeutic mechanism in nearly 40 years, suggesting the dawn of "a new era of endothelin research," the company said.

FDA 122

FDA 122

STAT

APRIL 23, 2024

But the agency noted in a press release that it’s the largest year-over-year update for NIH-funded postdocs since 2017. The 8% pay bump is far short of the increase to $70,000 that was recommended by an NIH working group late last year.

136

136

Med Ed 101

DECEMBER 5, 2017

Day 3 at ASHP 2017 has been a little more depressing due to the pharmacist job market. The post Pharmacist Job Market Outlook – ASHP Midyear 2017 Day 3 (Tuesday) appeared first on Med Ed 101. The post Pharmacist Job Market Outlook – ASHP Midyear 2017 Day 3 (Tuesday) appeared first on Med Ed 101.

40

40

STAT

APRIL 3, 2024

That was until 2017, when he founded a startup called Nucleai. For around 20 years, Avi Veidman spent his days in the Israeli intelligence community, analyzing satellite images. Now, he’s scouring biopsy samples for cancer cells. Nucleai’s technology is not searching out signs of danger.

137

137

Pharmacy Times

DECEMBER 21, 2023

The cost of defending license matters and malpractice claim costs have increased over a 5-year period (2017-2022).

132

132

Med Ed 101

NOVEMBER 30, 2016

As a practicing pharmacist, I continue to hear rumblings and news trickle in about the 2017 pharmacy job outlook. As I focus ahead to the 2017 pharmacy job outlook, Pharmacist […]. The post The 2017 Pharmacy Job Outlook – What A Facebook Ad Can Tell Us appeared first on Med Ed 101.

40

40

The Guardian - Pharmaceutical Industry

APRIL 20, 2024

An analysis of disclosures by medical device companies found that between 2017 and 2019 they reported €425m (£367m at today’s rates) in payments to healthcare organisations in Europe, according to the study in the journal Health Policy and Technology. Continue reading.

Hospitals 92

Hospitals 92

STAT

APRIL 23, 2024

Case in point: Under the seemingly benign title, “Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval,” an article published recently in the Journal of the American Medical Association claims that among “cancer drugs granted accelerated approval from 2013 to 2017, 41% (19/46) did not improve (..)

FDA 112

FDA 112

Fierce Pharma

DECEMBER 6, 2023

In 2017, Daiichi's former subsidiary Plexxikon alleged that Novartis stepped on its Zelboraf patents with its GSK-acquired medicine Tafinlar. After years of back and forth with Daiichi Sankyo over cancer drug patent claims, Novartis has thrown in the towel with a $182 million settlement. |

123

123

STAT

APRIL 11, 2024

In 2017, after receiving reports about the telehealth site, an investigator for the California medical board logged on to Lemonaid using an alias. Ho Anh had just started working at Lemonaid Health when he was caught up in a sting.

137

137

Med Ed 101

AUGUST 30, 2017

The post 2017 Pharmacist Board Certification Pass Rates – How Hard is BCPS, BCACP, BCGP, etc. I breakdown the recent release from Board of Pharmaceutical Specialties and give you a sense of what you are up against. If you are looking for study material for pharmacist board certifications, click […].

40

40

Fierce Pharma

JULY 27, 2023

scored a legal win in the insurance case tied to the 2017 "NotPetya" cyberattack, the case is in appeals—again. scored a legal win in the insurance case tied to the 2017 "NotPetya" cyberattack, the case is in appeals—again. About a month and a half after Merck & Co. That didn't take long.

Insurance 98

Insurance 98

Pharmaceutical Technology

NOVEMBER 28, 2023

Venture financing for innovative radiopharmaceutical drugs witnessed an approximately 550% increase from $63m in 2017 to $408m in 2023 YTD (year-to-date) total deal value in the US.

98

98

Fierce Pharma

NOVEMBER 7, 2023

Since launching the Regeneron-partnered antibody Dupixent in 2017, Sanofi has relied on the star medicine for sales growth.

Communication 98

Communication 98

Pharmacy Times

DECEMBER 9, 2022

The decision is updated from a 2017 recommendation to screen people for obstructive sleep apnea, which can lead to daytime sleepiness and other adverse outcomes.

139

139

Fierce Pharma

JANUARY 24, 2024

Apotex and two of its generics peers have agreed to settle with direct purchasers of their drugs in a price-fixing case that stretches all the way back to 2017. Over the years, myriad generic drugmakers have had to ante up fines and settlement fees for allegedly colluding on the prices of copycat drugs.

95

95

Pharmacy Times

DECEMBER 22, 2022

Alex Barker founded The Happy PharmD to provide career coaching and career development classes, and since 2017, the company has helped over 1,500 pharmacists.

132

132

STAT

APRIL 7, 2024

years after accelerated approval for cancer drugs to be pulled from the market if follow-up trials didn’t show a benefit; by 2017, that timing dropped to 3.6 The study also found evidence that drugs granted accelerated approval, meant to be a temporary designation, are spending less time in limbo. In 2013, it took an average of 9.9

FDA 144

FDA 144

STAT

MARCH 25, 2024

The initial effort to raise and sell chickens without using antibiotics began in 2017 as the company bet consumers would absorb the added expense. Continue to STAT+ to read the full story…

Labelling 136

Labelling 136

STAT

MARCH 26, 2024

By comparison, the FDA inspected 976 clinical study sites in 2017. In 2022, the health regulator inspected 537 hospitals and clinics that were conducting studies of medicines for which drug manufacturers were seeking approvals.

FDA 126

FDA Hospitals 126

STAT

DECEMBER 4, 2023

“We looked at anything and everything,” said Novak, who stepped down as CEO in 2017 but remained on the board until this year.  His company, along with two others, were founded to commercialize the new revolutionary gene-editing tool CRISPR-Cas9 , which promised to cure numerous genetic diseases.

Documentation 145

Documentation 145

Drug Store News

AUGUST 3, 2023

After reviewing products projected to succeed from 2017 to 2022, the categories with the largest number of new items on shelves are first aid, pain relief, oral care and eye and ear care.

97

97

Fierce Pharma

NOVEMBER 20, 2023

Patients with ultra-rare desmoid tumors now have an FDA-approved treatment, thanks to a drug made by SpringWorks Therapeutics, which spun out of Pfizer in 2017 with a portfolio of rare disease candidates. Thanks to a new FDA approval, patients with ultra-rare desmoid tumors now have an FDA-approved treatment.

FDA 99

FDA 99

STAT

MARCH 5, 2024

The first continuous glucose monitor was approved by the FDA in 2017. The sensor will pair with a smartphone app, which will provide blood glucose measurements every 15 minutes. Dexcom has not yet released the price of the device.

FDA 144

FDA 144